Matthew T. Ballo, MD, recently received dual appointments as founding chairman of the new Department of Radiation Oncology at the University of Tennessee Health Science Center and director of Radiation Oncology at The UT/West Cancer Center.
… there’s no reason for anyone to “battle their speech all alone,” said Tricia Hedinger, clinical assistant professor in the University of Tennessee’s Department of Audiology and Speech Pathology.
The University of Tennessee Health Science Center’s College of Nursing has launched an online certificate program for experienced nurse practitioners.
Dr. Matthew T. Ballo has received appointments as founding chairman of the new Department of Radiation Oncology at the University of Tennessee Health Science Center and director of radiation oncology at the UT/West Clinic… Ballo will play a key role in expanding the radiation/oncology program at UT/West Clinic. He also has plans to develop a radiation oncology… Read More
This is part of a series on pediatric healthcare challenges in this region. Organizations profiled in this series include the BLUES Project, which is part of the University of Tennessee Health Science Center and is fighting infant mortality
University of Memphis: 678-2000, memphis.edu. … Mar. 20: UTHSC/Urban Child Institute: Norfleet Forum for the Advancement of Health: “Early Brain Development and Function: Impact on Social and Health Outcomes,” 7:15a–3:30p, 385-4242, urbanchildinstitute.org/brain-awareness-2014.
The event is part of the 2014 Norfleet Forum for the Advancement of Health, presented by the Urban Child Institute, the University of Tennessee Health Science Center Department of Preventive Medicine, the UTHSC Neuroscience Institute and the Community Foundation of Greater Memphis. The forum is open to the public, health care workers and researchers for… Read More
Dr. Ari VanderWalde, the new associate vice chancellor of clinical trial research at the University of Tennessee Health Science Center said cases like Josh’s are extremely complicated, highly charged and center not only on the patient seeking an unproven drug, but the risk of jeopardizing others in the future who would get it.
